Position in NVO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$539,612
+$125,954 QoQ
Shares Held
11,256
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#686
of 1,347 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $10,204,212 across 14 Drug Manufacturers - General names. NVO ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,220 | $3,326,680 | |
| 2 | JNJ |
Johnson & Johnson
|
8,020 | $2,036,839 | |
| 3 | AMGN |
Amgen Inc
|
3,675 | $1,330,791 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,055 | $1,017,668 | |
| 5 | LLY |
ELI LILLY & Co
|
641 | $768,834 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
11,256 | $539,612 | |
| 7 | PFE |
Pfizer Inc
|
18,621 | $448,393 | |
| 8 | NVS |
Novartis AG
|
1,774 | $278,021 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $539,612 | 11,256 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $413,658 | 11,256 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $572,705 | 11,256 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $631,420 | 11,379 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $776,889 | 11,256 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $781,616 | 11,256 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $968,241 | 11,256 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,332,988 | 11,195 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,621,526 | 11,360 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,458,624 | 11,360 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,173,640 | 11,345 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,028,622 | 11,311 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $915,148 | 5,655 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $899,936 | 5,655 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $765,347 | 5,655 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $559,721 | 5,618 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $626,013 | 5,618 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $623,878 | 5,618 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $603,456 | 5,388 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $378,183 | 3,939 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $707,437 | 8,445 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $8,445 | 569,379 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $589,883 | 8,445 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $589,807 | 8,495 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $556,187 | 8,494 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $511,218 | 8,492 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||